Back to Equities

BRO

Brown & Brown, Inc.
Insurance · Insurance Brokerage & Distribution
Moat Mapper
Is the advantage durable?
Myth Meter
Is sentiment detached from reality?
Consolidation Calibrator
Is M&A creating value?
Gravy Gauge
Is this revenue durable?
Stress Scanner
What breaks under stress?
5
Lenses Applied
9
Signals Analyzed
5
Debates Resolved
7
Forecast Markets
The Central Question
"Brown & Brown's stock declined 44% over the trailing year as organic revenue growth decelerated to 2.8% and OpenAI received the first regulatory approval for an AI-driven insurance application. The operating business, meanwhile, delivered +23% revenue, +10% adjusted EPS, +24% cash flow growth, and the 32nd consecutive annual dividend increase. Is the market pricing existential AI disruption that has not yet arrived, or are real cyclical headwinds (CAT property rate trough, casualty rate moderation, investment income reversal, Howden talent lift, Accession integration) justifying the drawdown?"

Brown & Brown is the third-largest publicly traded U.S. insurance brokerage by revenue, headquartered in Daytona Beach, FL, with roots dating to 1939. The company operates two segments: Retail (direct brokerage to middle and upper-middle market customers) and Specialty Distribution (Arrowhead Intermediaries, formed in Q3 2025 by combining Programs, Wholesale, and the new Accession 180 division — collectively placing approximately $20 billion of written premium across more than 100 MGAs and MGUs). The Accession acquisition (closed Aug 2025) added roughly 5,000 teammates and ~$1.7-1.8B of annualized revenue, making it the largest deal in BRO's history. As a broker, BRO does not bear underwriting risk; revenue derives from commissions on placed premium plus contingent commissions linked to carrier underwriting profitability.

Executive Summary

Cross-lens roll-up assessment

Brown & Brown is operating well in the most challenged narrative environment of its public history. FY2025 produced +23% revenue, +10% adjusted EPS, +24% cash flow, +70 bps margin expansion to 35.9% adjusted EBITDAC, the 32nd consecutive annual dividend increase, and a $1.5B share repurchase authorization. The 44% stock decline appears to price existential AI disruption that has not yet materialized for middle-market commercial insurance brokerage, alongside genuine but cyclical headwinds (CAT property -25% rate trough, casualty rate moderation, investment income reversal, Accession integration costs through 2028, Howden talent lift). The moat thesis (state-by-state licensing, 100+ carrier contingent commission relationships, decentralized 24,000+ teammate culture, multi-line/multi-geography complexity for upper-middle-market accounts) remains structurally sound against current-generation AI distribution, which targets the SME tail. However, the narrative-versus-fundamentals gap is real, and management must execute on Accession integration and reaccelerate organic growth in 2026 to restore investor confidence.

Higher Scrutiny RequiredMEDIUM confidence

The fundamentals do not justify a broken-business narrative, but real cyclical pressures and the credibility gap on AI disruption mean investors should monitor Accession integration progress, Q1/Q2 2026 organic growth cadence, and Howden customer attrition before drawing conclusions about secular versus cyclical interpretation.

Key Takeaways

  • NARRATIVE_REALITY_GAP is SIGNIFICANT_GAP: 44% stock decline diverges from FY2025 operating reality (+23% revenue, +10% EPS, +24% cash flow, +70 bps margin expansion, 32nd consecutive dividend increase, $1.5B buyback authorization). Genuine cyclical headwinds justify 15-25% multiple compression, not 44%.
  • COMPETITIVE_POSITION is DURABLE: Middle-to-upper-middle market relationship brokerage with state-by-state licensing, 100+ carrier contingent commission economics, and 24,000+ teammate decentralized culture is structurally insulated from current-generation AI distribution, which targets SME tail (sub-$50K premium accounts where BRO does not compete heavily).
  • REVENUE_DURABILITY is CONDITIONAL: 2.8% FY25 organic reflects long-stated mid-single-digit baseline, not collapse — but multiple cyclical headwinds (CAT property -25% rates, casualty rate moderation, investment income reversal, Howden departures, Accession integration drag) compound in 2026. M&A provided ~20pts of the 23% total revenue growth.
  • CAPITAL_DEPLOYMENT is STRETCHED: Accession is the largest deal in BRO history with integration through 2028. Q4 2025 already missed revenue guidance by $25-45M. $30-40M synergies in 2026 are credible but back-end loaded. Long-term margin target raised from 30-35% to 32-37% — aggressive and synergy-dependent.
  • FUNDING_FRAGILITY is ROBUST: $1.45B FY25 cash flow at 24.6% revenue conversion is best-in-class. 32-year dividend increase streak, $1.5B buyback authorization, and continuing M&A pipeline reflect financial flexibility. The balance sheet supports the thesis even through extended narrative pressure.

Key Tensions

  • Cyclical versus secular interpretation: Is the organic deceleration to 2.8% a return to baseline (cyclical, recovers as Accession SD businesses contribute in H2 2026) or the start of secular AI-driven erosion of broker share?
  • Accession execution timing: Q4 2025 revenue miss is a yellow flag. The $30-40M synergies guided for 2026 are back-end loaded, and integration runs through 2028 — leaving multiple quarters of incremental execution risk before the deal's economics are fully visible.
  • AI disruption salience: OpenAI's insurance app approval is a real catalyst, but its impact concentrates in SME / personal lines distribution, not the middle-market commercial book where BRO operates. The narrative may have over-applied SME disruption logic to middle-market complexity.

Moat Mapper

Is competitive advantage durable?

About this lens

Key Metrics

Competitive Position
DURABLE
FRAGILE
CONTESTED
DEFENSIBLE
DURABLE
Governance Alignment
STRONG
WEAK
MIXED
ADEQUATE
STRONG

Key FindingsClick to expand details

Signal AssessmentsClick for full context

SignalAssessment
Competitive Position
DURABLE
Governance Alignment
STRONG

Model Debates

Cross-Lens Insights

Where Lenses Agree

  • Organic growth deceleration is a return to long-stated baseline, not collapse — confirmed by Gravy Gauge and Myth Meter, which both observe 16+ years of mgmt guidance for low-to-mid single-digit organic in steady-state
  • AI disruption fear targets SME tail; BRO's middle-to-upper-middle market book is structurally insulated — Moat Mapper and Myth Meter converge on this customer-mix distinction
  • Cash flow durability ($1.45B at 24.6% conversion) is best-in-class and the under-recognized strength — confirmed across Gravy Gauge, Stress Scanner, and Myth Meter
  • Accession integration is the highest-impact execution variable for 2026-2028 — Consolidation Calibrator and Stress Scanner converge on Q4 2025 revenue miss as the first datapoint to monitor
  • Founder-family alignment plus the 32-year dividend increase streak plus the $1.5B buyback authorization signal durable governance commitment to shareholder returns — Moat Mapper and Stress Scanner converge

Where Lenses Differ

REVENUE_DURABILITY
Gravy Gauge:CONDITIONAL
Moat Mapper:DURABLE moat with cyclical revenue pressure

The lenses agree on time-horizon distinction. Near-term (12-24 months): CONDITIONAL due to multiple compounding cyclical headwinds (CAT property, investment income, Howden, Accession integration). Long-term (5+ years): the moat thesis dominates if AI disruption stays in SME segment. Investors should distinguish cyclical from secular pressures.

The following publicly available documents were collected and extracted into a structured fact dossier that powered this analysis.

SEC Filing
  • Annual Report (10-K) — FY2025
  • Quarterly Report (10-Q) — Q3 2025
  • Definitive Proxy Additional Materials (DEFA14A) — March 2026
  • Current Report (8-K) — Q1 2026 (April 2026)
  • Current Report (8-K) — Q4 2025 Earnings
  • Form 4 Insider Transaction Filings (5 filings, Feb-Mar 2026)
Earnings Transcript
  • Q1 2025 Earnings Call Transcript
  • Q2 2025 Earnings Call Transcript
  • Q3 2025 Earnings Call Transcript
  • Q4 2025 Earnings Call Transcript